tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market
Advertisement

MaaT Pharma (MAAT) Income Statement

Compare
3 Followers

MaaT Pharma Income Statement

Last quarter (Q4 2024), MaaT Pharma's total revenue was €1.50M, an increase of 59.72% from the same quarter last year. In Q4, MaaT Pharma's net income was €-16.05M. See MaaT Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 3.22M€ 2.23M€ 1.43M€ 972.00K€ 0.00
Gross Profit
€ 1.97M€ 1.66M€ 1.09M€ 806.00K€ -164.00K
Operating Expenses
€ 30.39M€ 21.29M€ 14.65M€ 9.70M€ 5.25M
Depreciation and Amortization
€ 1.69M€ 871.00K€ 429.00K€ 328.00K€ 164.00K
EBITDA
€ -26.34M€ -19.74M€ -13.31M€ -8.71M€ -6.58M
Operating Income
€ -28.43M€ -19.94M€ -13.56M€ -8.89M€ -5.25M
Other Income/Expenses
€ -3.99M€ 226.00K€ -156.00K€ -126.00K€ -49.00K
Pretax Income
€ -32.42M€ -19.72M€ -13.71M€ -9.02M€ -5.30M
Net Income
€ -28.90M€ -19.72M€ -13.87M€ -9.14M€ -5.35M
Per Share Metrics
Basic EPS
€ -2.20€ -1.73€ -1.40€ -3.77€ -25.91
Diluted EPS
€ -2.20€ -1.73€ -1.40€ -3.77€ -25.91
Weighted Average Shares Outstanding
13.06M 11.37M 9.89M 2.43M 206.46K
Weighted Average Shares Outstanding (Diluted)
13.06M 11.37M 9.89M 2.43M 206.46K
Currency in EUR

MaaT Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis